Billings Clinic
Especially For:

Clinical Trials

Title   Type 2 Diabetes (SUSTAIN 1)
Description   Efficacy and safety of semaglutide once-weekly versus placebo in drug-naive subjects with type 2 diabetes
IRB Number   SUSTAIN 1
Category   Diabetes
Inclusion/Notes   You may qualify to participate if you:
* Diagnosed with Type 2 diabetes and treated with diet and exercise for at least 30 days
* Age 18 or older
* HbA1c between 7.0% and 10.0%
Status   Currently Enrolling
Start Date   09/26/2013
Principal Investigator (PI)   Christopher Sorli, MD
Physician Profile   Christopher Sorli MD
Contact Name   Recruitment Nurse
Contact Email   Marilyn Lindell
Phone   (406) 657-4111
Alternate Phone   (800) 996-2663
Fax   (406) 247-6512
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.